Læknablaðið

Ukioqatigiit

Læknablaðið - 15.11.1997, Qupperneq 10

Læknablaðið - 15.11.1997, Qupperneq 10
726 LÆKNABLAÐIÐ 1997; 83 Lyfjaofnæmi og lyfjaóþol meðal 20-44 ára íslendinga Faraldsfræðileg könnun Halla Skúladóttir, Davíð Gíslason, Þórarinn Gíslason Skúladóttir H, Gíslason D, Gíslason Þ Allergic and pseudo-allergic reactions to drugs in an Icelandic urban population 20-44 years of age Læknablaðið 1997; 83: 726-30 Objective: Allergic or pseudo-allergic reactions to drugs are common complaints. The symptoms vary from mild to life threatening. Although the mecha- nisms for most drug reactions are unknown or un- certain such reactions are believed to be more com- mon among atopic individuals. Our goal was: 1) To estimate the prevalence of al- lergic and pseudo-allergic drug reactions in a ran- dom urban Icelandic population 20-AA years of age. 2) To search for the characteristics of symptoms and which drugs were involved in such reactions, 3) their association to atopy and atopic diseases and 4) to find possible risk factors. Material and methods: In the second stage of the European Community Respiratory Health Survey an urban population 20-44 years of age was invited to participate. In Iceland altogether 545 answered an additional question: Have you at any time had allergic reaction to drugs? Those who answered yes to this question were contacted later by telephone and asked further about drug allergy. Rcsults: Altogether 77 (14%) replied yes to the question, more females (19%) than males (9%) (p<0.001). Atopic individuals (with one or more positive prick tests) and those with nasal allergies, eczema, urticaria and illness caused by eating a par- ticular food or foods reported allergic drug reactions more often (p<0.05). IgE geometric mean value was 17.5 kU/L for those who reported allergic drug reaction compared to 12.6 kU/L among the others (p=0.08). The most common symptoms associated with drugs were skin symptoms (urticaria, angioneu- rotic edema), symptoms from respiratory organs Frá Vífilstaðaspítala. Fyrirspurnir, bréfaskipti: Davíð Gisla- son, Vífilsstaðaspítala, 210 Garðabær, sími 560 2800. and fever. With further inquiries by telephone 13/64 denied drug allergy. Thus 51/64 (80%) withheld their questionnaire answers. Antibiotics were most often blamed for drug reactions, followed by anaes- thetics, NSAID and opiates. Conclusion: There was a correlation between re- ported drug reactions and atopy and/or atopic dis- eases. The drug reactions were more than twice as common in women as in men. The only comparable study we know of, shows the prevalence of drug reactions on the same level as in Iceland. Ágrip Inngangur: Kvartanir um lyfjaofnæmi eru algengar og geta verið af ýmsum toga; allt frá því að vera smávægileg óþægindi til lífshættu- legs ástands. Þótt eðli flestra lyfjaviðbragða sé óþekkt er talið að einstaklingar með bráðaof- næmi (atopy) og/eða aðra ofnæmissjúkdóma (atopic diseases) fái þau frekar en aðrir. Mark- mið þessarar rannsóknar var: 1) að kanna hversu algengt væri að þéttbýlisfólk á aldrinum 20-44 ára teldi sig hafa lyfjaofnæmi, 2) að kanna hvaða einkenni og lyf tengdust meintu lyfjaofnæmi, 3) að kanna tengsl lyfjaofnæmis við ofnæmi og ofnæmissjúkdóma og 4) meta áhættuþætti. Efniviður og aðferðir: í öðrum áfanga rann- sóknarinnar Lungu og heilsa var íbúurn á Reykjavíkursvæðinu á aldrinum 20-44 ára boðið til þátttöku. Spurt var viðbótarspurning- ar um lyfjaofnæmi og samtals svöruðu 545 spurningunni: Hefur þú fengið ofnæmisein- kenni af lyfjum? Nokkru síðar var aftur haft samband við þá sem svöruðu spurningunni ját- andi og þeir spurðir nánar um lyfjaofnæmi. Niðurstöður: Sjötíu og sjö (14%) svöruðu spurningunni játandi. Tvöfalt fleiri konur (19%) en karlar (9%) töldu sig hafa lyfjaof-
Qupperneq 1
Qupperneq 2
Qupperneq 3
Qupperneq 4
Qupperneq 5
Qupperneq 6
Qupperneq 7
Qupperneq 8
Qupperneq 9
Qupperneq 10
Qupperneq 11
Qupperneq 12
Qupperneq 13
Qupperneq 14
Qupperneq 15
Qupperneq 16
Qupperneq 17
Qupperneq 18
Qupperneq 19
Qupperneq 20
Qupperneq 21
Qupperneq 22
Qupperneq 23
Qupperneq 24
Qupperneq 25
Qupperneq 26
Qupperneq 27
Qupperneq 28
Qupperneq 29
Qupperneq 30
Qupperneq 31
Qupperneq 32
Qupperneq 33
Qupperneq 34
Qupperneq 35
Qupperneq 36
Qupperneq 37
Qupperneq 38
Qupperneq 39
Qupperneq 40
Qupperneq 41
Qupperneq 42
Qupperneq 43
Qupperneq 44
Qupperneq 45
Qupperneq 46
Qupperneq 47
Qupperneq 48
Qupperneq 49
Qupperneq 50
Qupperneq 51
Qupperneq 52
Qupperneq 53
Qupperneq 54
Qupperneq 55
Qupperneq 56
Qupperneq 57
Qupperneq 58
Qupperneq 59
Qupperneq 60
Qupperneq 61
Qupperneq 62
Qupperneq 63
Qupperneq 64
Qupperneq 65
Qupperneq 66
Qupperneq 67
Qupperneq 68
Qupperneq 69
Qupperneq 70
Qupperneq 71
Qupperneq 72
Qupperneq 73
Qupperneq 74
Qupperneq 75
Qupperneq 76
Qupperneq 77
Qupperneq 78
Qupperneq 79
Qupperneq 80
Qupperneq 81
Qupperneq 82
Qupperneq 83
Qupperneq 84

x

Læknablaðið

Direct Links

Hvis du vil linke til denne avis/magasin, skal du bruge disse links:

Link til denne avis/magasin: Læknablaðið
https://timarit.is/publication/986

Link til dette eksemplar:

Link til denne side:

Link til denne artikel:

Venligst ikke link direkte til billeder eller PDfs på Timarit.is, da sådanne webadresser kan ændres uden advarsel. Brug venligst de angivne webadresser for at linke til sitet.